CIRM Publications

Monthly E-Newsletters
Grantee Publications
Annual Reports
Workshop Reports
Strategic Plans
Staff Reports
Staff Publications
Whitepapers on Advancing Stem Cell Therapies
Commissioned Reports
Financial Statements

Monthly E-Newsletters

It’s hard to keep track of all the stem cell advances each month. That’s why we summarize the month’s news, events and upcoming dates to remember. You can subscribe to receive these newsletters each month by RSS feed or by email.

Read all monthly newsletters
Sign up to receive newsletters

Grantee Publications

Each scientific publication by our grantees describes an advance that could ultimately lead to new therapies.

See all publications by CIRM grantees

Annual Reports

Our annual report describes research advances, tells patient stories and proves insights about CIRM’s impact on regenerative medicine from our chair and president.

View older Annual Reports

Workshop Reports

Our workshops bring together experts in areas we think are going to be important in the development of new stem cell-based therapies.

Read all CIRM workshop reports

Strategic Plans

Our efforts are guided by a set of clear goals laid out in our strategic plan, which we update every few years to reflect changes in the field.

Strategic Plan 2022 – Real Life [pdf]
Strategic Plan 2016 and Beyond [pdf]
Scientific Strategic Plan (May 2012) [pdf]
Scientific Strategic Plan (October 2009) [pdf]
Scientific Strategic Plan (December 2006) [pdf]

Staff Reports

The Promise on Hold: A Preliminary Assessement of the Impace of the NIH Stem Cell Funding Freeze [pdf]
CIRM Transition Plan [pdf]

Staff Publications

Our staff members publish regularly in high-profile journals where their insights help guide the field.

See all publications by CIRM staff

Whitepapers on Advancing Stem Cell Therapies

On June 25, 2013, The California Institute for Regenerative Medicine (CIRM), the Alliance for Regenerative Medicine (ARM), and the Cell Therapy Catapult (Catapult) convened a roundtable on June 25, 2013 to define technological challenges and identify potential solutions in three key areas:

Manufacturing clinical-grade cell products derived from stem cells
Characterizing the cell product
Imaging cells post transplantation.

This white paper summarizes the proceedings from the roundtable and highlights key recommendations

Key Tools and Technology Hurdles in Advancing Stem-Cell Therapies [pdf]

In June 2014, The California Institute for Regenerative Medicine (CIRM) convened a workshop that followed up on the 2013 Key Tools and Technology Hurdles Roundtable. The 2014 workshop further discussed technological challenges and included a proposal for a CIRM sponsored Manufacturing Center of Excellence. This white paper summarizes the proceedings from the workshop and highlights key discourse.

Manufacturing Center of Excellence Report [pdf]

Commissioned Reports

We periodically commission reports by outside experts to clarify the impact of the agency on health care and the economy and to assess our effectiveness.

Economic Impacts of the California Institute for Regenerative Medicine (CIRM) (2019) [pdf]
Future Health Dividend (2019) [pdf]
Investing in translational research to produce clinical, commercial and financial outcomes (2013) [pdf]
Updated economic impact report (2012) [pdf]
Report of the CIRM External Advisory Committee [pdf]
Coverage, Cost-Control Mechanisms, and Financial Risk-Sharing Alternatives of High-Cost Health Care Technologies [pdf]
Supporting Diversity in Research Participation: A Framework for Action [pdf]
Economic Impact of Research Funded by the California Institute for Regenerative Medicine (2010) [pdf]

Financial Statements

We are proud of our record of fiscal responsibility. Our funding for administrative costs remains below 6% of our total expenses each year. These yearly financial statements provide details about where our money is spent.

2018-19 Financial Statement.pdf

2019-20 Financial Statements.pdf